Westin, J., Davis, R. E., Feng, L., Hagemeister, F., Steiner, R., Lee, H. J., Fayad, L., Nastoupil, L., Ahmed, S., Rodriguez, A., Fanale, M., Samaniego, F., Iyer, S. P., Nair, R., Oki, Y., Fowler, N., Wang, M., Ma, M. C. J., Vega, F., McDonnell, T., Pinnix, C., Griffith, D., Lu, Y., Tewari, S., Sun, R., Scott, D. W., Flowers, C. R., Neelapu, S., & Green, M. R. (2023). smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma. Journal of clinical oncology, 41(4), 745–755. http://access.bl.uk/ark:/81055/vdc_100179397579.0x000027